BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23991242)

  • 1. Venom of the Brazilian spider Sicarius ornatus (Araneae, Sicariidae) contains active sphingomyelinase D: potential for toxicity after envenomation.
    Lopes PH; Bertani R; Gonçalves-de-Andrade RM; Nagahama RH; van den Berg CW; Tambourgi DV
    PLoS Negl Trop Dis; 2013; 7(8):e2394. PubMed ID: 23991242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelinase D Activity in
    Lopes PH; Fukushima CS; Shoji R; Bertani R; Tambourgi DV
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicological Characterization and Phospholipase D Activity of the Venom of the Spider
    Arán-Sekul T; Perčić-Sarmiento I; Valencia V; Olivero N; Rojas JM; Araya JE; Taucare-Ríos A; Catalán A
    Toxins (Basel); 2020 Nov; 12(11):. PubMed ID: 33171968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for the toxic potential of Loxosceles amazonica and Loxosceles willianilsoni spiders' venoms.
    Lopes PH; Fukushima CS; Shoji R; Bertani R; Tambourgi DV
    Toxicon; 2021 Feb; 191():1-8. PubMed ID: 33347860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analyses of venoms from American and African Sicarius spiders that differ in sphingomyelinase D activity.
    Zobel-Thropp PA; Bodner MR; Binford GJ
    Toxicon; 2010 Jun; 55(7):1274-82. PubMed ID: 20144895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Loxosceles spider Sphingomyelinase D with small-molecule inhibitors as a potential therapeutic approach for loxoscelism.
    Lopes PH; Murakami MT; Portaro FCV; Mesquita Pasqualoto KF; van den Berg C; Tambourgi DV
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):310-321. PubMed ID: 30734604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular evolution, functional variation, and proposed nomenclature of the gene family that includes sphingomyelinase D in sicariid spider venoms.
    Binford GJ; Bodner MR; Cordes MH; Baldwin KL; Rynerson MR; Burns SN; Zobel-Thropp PA
    Mol Biol Evol; 2009 Mar; 26(3):547-66. PubMed ID: 19042943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phylogenetic distribution of sphingomyelinase D activity in venoms of Haplogyne spiders.
    Binford GJ; Wells MA
    Comp Biochem Physiol B Biochem Mol Biol; 2003 May; 135(1):25-33. PubMed ID: 12781970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
    Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingomyelinase D in sicariid spider venom is a potent insecticidal toxin.
    Zobel-Thropp PA; Kerins AE; Binford GJ
    Toxicon; 2012 Sep; 60(3):265-71. PubMed ID: 22561243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the complement system in kidney cell death induced by Loxosceles venom Sphingomyelinases D.
    Okamoto CK; van den Berg CW; Pohl PC; Tambourgi DV
    Arch Toxicol; 2024 May; 98(5):1561-1572. PubMed ID: 38498159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not as docile as it looks? Loxosceles venom variation and loxoscelism in the Mediterranean Basin and the Canary Islands.
    Planas E; Zobel-Thropp PA; Ribera C; Binford G
    Toxicon; 2015 Jan; 93():11-9. PubMed ID: 25449105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the toxic potential of venom from Loxosceles adelaida, a Brazilian brown spider from karstic areas.
    Pretel F; Gonçalves-de-Andrade RM; Magnoli FC; da Silva ME; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):449-58. PubMed ID: 15733566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and genotoxic effects on human keratinocytes triggered by sphingomyelinase D from Loxosceles venom.
    da Silva MS; Lopes PH; Elias MC; Tambourgi DV
    Arch Toxicol; 2020 Oct; 94(10):3563-3577. PubMed ID: 32607614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Web of Coagulotoxicity: Failure of Antivenom to Neutralize the Destructive (Non-Clotting) Fibrinogenolytic Activity of
    Grashof D; Zdenek CN; Dobson JS; Youngman NJ; Coimbra F; Benard-Valle M; Alagon A; Fry BG
    Toxins (Basel); 2020 Jan; 12(2):. PubMed ID: 32019058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.
    de Oliveira KC; Gonçalves de Andrade RM; Piazza RM; Ferreira JM; van den Berg CW; Tambourgi DV
    Toxicon; 2005 Mar; 45(4):421-9. PubMed ID: 15733563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loxosceles venom Sphingomyelinase D activates human blood leukocytes: Role of the complement system.
    Manzoni-de-Almeida D; Squaiella-Baptistão CC; Lopes PH; van den Berg CW; Tambourgi DV
    Mol Immunol; 2018 Feb; 94():45-53. PubMed ID: 29257998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From taxonomy to molecular characterization of brown spider venom: An overview focused on Loxosceles similis.
    Oliveira-Mendes BBR; Chatzaki M; Sales-Medina DF; Leal HG; van der Veer R; Biscoto GL; Gonçalves PM; Soares da Silva T; Guerra-Duarte C; Kalapothakis E; Horta CCR
    Toxicon; 2020 Jan; 173():5-19. PubMed ID: 31726080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetracycline protects against dermonecrosis induced by Loxosceles spider venom.
    Paixão-Cavalcante D; van den Berg CW; Gonçalves-de-Andrade RM; Fernandes-Pedrosa Mde F; Okamoto CK; Tambourgi DV
    J Invest Dermatol; 2007 Jun; 127(6):1410-8. PubMed ID: 17218940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.